Our study reveals that lymphoid enhancer‐binding factor 1 (LEF1), a central transcription factor for Wnt/β‐catenin signaling, is expressed in experimentally generated tumor‐promoting CAFs (exp‐CAFs) as well as in CAFs from breast cancer patients, particularly those with a poor prognosis. This evidence concerns the gene LEF1 and breast carcinoma.